METOPIRONE Side Effects

7012354-0 | Blood Corticotrophin Decreased, Blood Cortisol Decreased, Blood Cortisol Increased, Headache, Hyponatraemia, Hypophysectomy, Malaise, Nausea, Pituitary Haemorrhage
on Sep 13, 2010 Female patient from JAPAN , weighting 107.6 lb, was diagnosed with pituitary-dependent cushing's syndrome, hypokalaemia, gastritis, hypothyroidism, prophylaxis, pneumonia (What is pneumonia?) and was treated with Metopirone (View Usage). Patient experienced the following unwanted or unexpected effects: blood corticotrophin decreased, blood cortisol decreased, blood cortisol increased, headache (What is headache?), hyponatraemia, hypophysectomy, malaise, nausea (What is nausea?), pituitary haemorrhage. Metopirone dosage: 250 Mg, Qid. During the same period patient was treated with DEXAMETHASONE (0.5 Mg) (View Dexamethasone Review and Dexamethasone Label ), SLOW K (2.4 G, Unk) (View Slow-k Review and Slow-k Label ), TAKEPRON (15 Mg, Unk) (View Takepron Review and Takepron Label ), THYRADIN S (25 Ug, Unk) (View Thyradin S Review and Thyradin S Label ), EPLERENONE (50 Mg, Unk) (View Eplerenone Review and Eplerenone Label ), SELBEX (200 Mg, Unk) (View Selbex Review and Selbex Label ), CRAVIT (300 Mg, Unk) (View Cravit Review and Cravit Label ).

7011989-9 | Cryptococcosis, Cytomegalovirus Infection, Depressed Level Of Consciousness, Interstitial Lung Disease, Pneumocystis Jiroveci Pneumonia, Respiratory Distress, Respiratory Failure
Patient was taking Metopirone (View Usage). Patient had the following side effects: cryptococcosis, cytomegalovirus infection (What is cytomegalovirus infection?), depressed level of consciousness, interstitial lung disease, pneumocystis jiroveci pneumonia, respiratory distress, respiratory failure on Sep 13, 2010 from JAPAN Additional patient health information: Female patient , 85 years of age, was diagnosed with acth-producing pituitary tumour, infection prophylaxis and. Metopirone dosage: 500 Mg Per Day. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (4 Df) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ).

6991952-4 | Cytomegalovirus Infection, Depressed Level Of Consciousness, Interstitial Lung Disease, Pneumocystis Jiroveci Pneumonia, Respiratory Distress, Respiratory Failure
Adverse event was reported on Sep 13, 2010 by a Female patient taking Metopirone (View Usage) (Dosage: 500 Mg Per Day) was diagnosed with acth-producing pituitary tumour, infection prophylaxis and. Location: JAPAN , 85 years of age, After Metopirone was administered, patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), depressed level of consciousness, interstitial lung disease, pneumocystis jiroveci pneumonia, respiratory distress, respiratory failure. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (4 Df) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ).

6831567-1 | Abortion Induced
on Jun 29, 2010 Female patient from FRANCE , 30 years of age, was treated with Metopirone (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced. Metopirone dosage: 03 G, Once. During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), DECTANCYL (View Dectancyl Review and Dectancyl Label ).


6716353-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Liver Function Test Abnormal, Mental Status Changes
on Feb 11, 2010 Female patient from UNITED STATES , weighting 145.5 lb, was diagnosed with ectopic acth syndrome, cushing's syndrome, hypertension, diabetes mellitus and was treated with Metopirone (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, liver function test abnormal, mental status changes. Metopirone dosage: 250 Mg, Tid. During the same period patient was treated with OCTREOTIDE ACETATE (View Octreotide Acetate Review and Octreotide Acetate Label ), HYDROCHLOROTHIAZIDE (25 Mg Every Day) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (40 Mg Every Day) (View Lisinopril Review and Lisinopril Label ), PERCOCET (View Percocet Review and Percocet Label ). Patient was hospitalized.

6702279-X | Blood Corticotrophin Decreased, Blood Cortisol Decreased, Blood Cortisol Increased, Headache, Hyponatraemia, Hypophysectomy, Malaise, Nausea, Pituitary Haemorrhage
Patient was taking Metopirone (View Usage). After Metopirone was administered, patient had the following side effects: blood corticotrophin decreased, blood cortisol decreased, blood cortisol increased, headache (What is headache?), hyponatraemia, hypophysectomy, malaise, nausea (What is nausea?), pituitary haemorrhage on Apr 19, 2010 from JAPAN Additional patient health information: Female patient , weighting 107.6 lb, was diagnosed with pituitary-dependent cushing's syndrome, hypokalaemia, gastritis, hypothyroidism, prophylaxis, pneumonia (What is pneumonia?) and. Metopirone dosage: 250 Mg, Qid. During the same period patient was treated with DEXAMETHASONE TAB (0.5 Mg) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), SLOW K (2.4 G, Unk) (View Slow-k Review and Slow-k Label ), TAKEPRON (15 Mg, Unk) (View Takepron Review and Takepron Label ), THYRADIN S (25 Ug, Unk) (View Thyradin S Review and Thyradin S Label ), EPLERENONE (50 Mg, Unk) (View Eplerenone Review and Eplerenone Label ), SELBEX (200 Mg, Unk) (View Selbex Review and Selbex Label ), CRAVIT (300 Mg, Unk) (View Cravit Review and Cravit Label ).

6690647-4 | Blood Corticotrophin Decreased, Blood Cortisol Decreased, Blood Cortisol Increased, Headache, Hyponatraemia, Hypophysectomy, Malaise, Nausea, Pituitary Haemorrhage
Adverse event was reported on Apr 14, 2010 by a Female patient taking Metopirone (View Usage) (Dosage: 250 Mg, Qid) was diagnosed with pituitary-dependent cushing's syndrome, hypokalaemia, gastritis, hypothyroidism, prophylaxis, pneumonia (What is pneumonia?) and. Location: JAPAN , weighting 107.6 lb, Patient experienced the following unwanted or unexpected effects: blood corticotrophin decreased, blood cortisol decreased, blood cortisol increased, headache (What is headache?), hyponatraemia, hypophysectomy, malaise, nausea (What is nausea?), pituitary haemorrhage. During the same period patient was treated with DEXAMETHASONE (0.5 Mg) (View Dexamethasone Review and Dexamethasone Label ), SLOW K (2.4 G, Unk) (View Slow-k Review and Slow-k Label ), TAKEPRON (15 Mg, Unk) (View Takepron Review and Takepron Label ), THYRADIN S (25 Ug, Unk) (View Thyradin S Review and Thyradin S Label ), EPLERENONE (50 Mg, Unk) (View Eplerenone Review and Eplerenone Label ), SELBEX (200 Mg, Unk) (View Selbex Review and Selbex Label ), CRAVIT (300 Mg, Unk) (View Cravit Review and Cravit Label ).

6682478-6 | Adrenal Insufficiency, Blood Pressure Decreased, Decreased Appetite, Infection, Nausea
on Apr 08, 2010 Female patient from JAPAN , 77 years of age, was diagnosed with cushing's syndrome and was treated with Metopirone (View Usage). Patient had the following side effects: adrenal insufficiency, blood pressure decreased, decreased appetite, infection (What is infection?), nausea (What is nausea?). Metopirone dosage: . During the same period patient was treated with DEXTROAMPHETAMINE (View Dextroamphetamine Review and Dextroamphetamine Label ). Patient was hospitalized.

6680811-2 | Adrenal Insufficiency, Blood Pressure Decreased, Decreased Appetite, Hypertension, Infection, Nausea
on Apr 08, 2010 Female patient from JAPAN , 77 years of age, was diagnosed with cushing's syndrome and was treated with Metopirone (View Usage). After Metopirone was administered, patient had the following side effects: adrenal insufficiency, blood pressure decreased, decreased appetite, hypertension, infection (What is infection?), nausea (What is nausea?). Metopirone dosage: . During the same period patient was treated with DEXTROAMPHETAMINE (View Dextroamphetamine Review and Dextroamphetamine Label ). Patient was hospitalized.

6678698-7 | Adrenal Insufficiency, Blood Pressure Decreased, Decreased Appetite, Hypertension, Nausea
Patient was taking Metopirone (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal insufficiency, blood pressure decreased, decreased appetite, hypertension, nausea (What is nausea?) on Apr 02, 2010 from JAPAN Additional patient health information: Female patient , 77 years of age, was diagnosed with cushing's syndrome and. Metopirone dosage: . During the same period patient was treated with DEXTROAMPHETAMINE (View Dextroamphetamine Review and Dextroamphetamine Label ). Patient was hospitalized.

6676442-0 | Blood Pressure Decreased, Decreased Appetite, Nausea
Adverse event was reported on Apr 02, 2010 by a Female patient taking Metopirone (View Usage) (Dosage: ) was diagnosed with cushing's syndrome and. Location: JAPAN , 77 years of age, Patient had the following side effects: blood pressure decreased, decreased appetite, nausea (What is nausea?). Patient was hospitalized.

6671717-3 | Adrenal Carcinoma
on Apr 02, 2010 Male patient from UNITED STATES , weighting 292.0 lb, was diagnosed with hypercorticoidism and was treated with Metopirone (View Usage). After Metopirone was administered, patient had the following side effects: adrenal carcinoma. Metopirone dosage: 250 Mg, Tid. During the same period patient was treated with MITOTANE (View Mitotane Review and Mitotane Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), INSULIN (View Insulin Review and Insulin Label ).

6658793-9 | Blood Pressure Decreased, Decreased Appetite, Nausea
on Mar 24, 2010 Female patient from JAPAN , 77 years of age, was diagnosed with cushing's syndrome and was treated with Metopirone (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, decreased appetite, nausea (What is nausea?). Metopirone dosage: . Patient was hospitalized.

6653135-7 | Blood Pressure Decreased, Mechanical Ventilation, Pseudomonas Infection, Respiratory Disorder, Septic Shock
Patient was taking Metopirone (View Usage). Patient had the following side effects: blood pressure decreased, mechanical ventilation, pseudomonas infection, respiratory disorder, septic shock on Mar 23, 2010 from JAPAN Additional patient health information: Female patient , 72 years of age, weighting 145.5 lb, was diagnosed with cushing's syndrome and. Metopirone dosage: 1500 Mg Daily. During the same period patient was treated with DIFLUCAN (100 Mg, Unk) (View Diflucan Review and Diflucan Label ), ADALAT CC (40 Mg, Unk) (View Adalat Cc Review and Adalat Cc Label ).

6602061-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Mental Status Changes
Adverse event was reported on Feb 11, 2010 by a Female patient taking Metopirone (View Usage) (Dosage: 250 Mg, Tid) was diagnosed with ectopic acth syndrome, cushing's syndrome, hypertension, diabetes mellitus and. Location: UNITED STATES , weighting 145.5 lb, After Metopirone was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, mental status changes. During the same period patient was treated with OCTREOTIDE ACETATE (View Octreotide Acetate Review and Octreotide Acetate Label ), HYDROCHLOROTHIAZIDE (25 Mg Every Day) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (40 Mg Every Day) (View Lisinopril Review and Lisinopril Label ), PERCOCET (View Percocet Review and Percocet Label ). Patient was hospitalized.

6599265-X | Pseudomonas Infection, Septic Shock
on Feb 19, 2010 Female patient from JAPAN , 72 years of age, weighting 145.5 lb, was diagnosed with cushing's syndrome and was treated with Metopirone (View Usage). Patient experienced the following unwanted or unexpected effects: pseudomonas infection, septic shock. Metopirone dosage: .

6581985-4 | Pseudomonas Infection, Septic Shock
on Feb 10, 2010 Female patient from JAPAN , 72 years of age, weighting 145.5 lb, was diagnosed with cushing's syndrome and was treated with Metopirone (View Usage). Patient had the following side effects: pseudomonas infection, septic shock. Metopirone dosage: .

6581982-9 | Cytomegalovirus Infection, Depressed Level Of Consciousness, Interstitial Lung Disease, Pneumocystis Jiroveci Pneumonia, Respiratory Distress, Respiratory Failure
Patient was taking Metopirone (View Usage). After Metopirone was administered, patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), depressed level of consciousness, interstitial lung disease, pneumocystis jiroveci pneumonia, respiratory distress, respiratory failure on Feb 10, 2010 from JAPAN Additional patient health information: Female patient , 85 years of age, was diagnosed with acth-producing pituitary tumour, infection prophylaxis and. Metopirone dosage: 500 Mg Per Day. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (4 Df) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ).

6528891-9 | Cytomegalovirus Infection, Depressed Level Of Consciousness, Interstitial Lung Disease, Pneumocystis Jiroveci Pneumonia, Respiratory Distress, Respiratory Failure
Adverse event was reported on Dec 18, 2009 by a Female patient taking Metopirone (View Usage) (Dosage: 500 Mg Per Day) was diagnosed with acth-producing pituitary tumour, infection prophylaxis and. Location: JAPAN , 85 years of age, Patient experienced the following unwanted or unexpected effects: cytomegalovirus infection (What is cytomegalovirus infection?), depressed level of consciousness, interstitial lung disease, pneumocystis jiroveci pneumonia, respiratory distress, respiratory failure. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (4 Df) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ).

6491319-1 | Pneumocystis Jiroveci Pneumonia
on Dec 09, 2009 Female patient from JAPAN , 85 years of age, was diagnosed with acth-producing pituitary tumour, infection prophylaxis and was treated with Metopirone (View Usage). Patient had the following side effects: pneumocystis jiroveci pneumonia. Metopirone dosage: 500 Mg Per Day. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (4 Df) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ).

6466235-1 | Agranulocytosis, Neutropenia
on Nov 20, 2009 Female patient from FRANCE , 58 years of age, was diagnosed with cushing's syndrome and was treated with Metopirone (View Usage). After Metopirone was administered, patient had the following side effects: agranulocytosis, neutropenia. Metopirone dosage: 750 Mg, Tid. Patient was hospitalized.

6348732-2 | Adrenocortical Insufficiency Acute, Anaemia, Blood Calcium Decreased, Blood Glucose Decreased, Blood Lactic Acid Decreased, Blood Pressure Decreased, Blood Pressure Diastolic Increased, Calcium Ionised Decreased, Glucose Tolerance Impaired
Patient was taking Metopirone (View Usage). Patient experienced the following unwanted or unexpected effects: adrenocortical insufficiency acute, anaemia, blood calcium decreased, blood glucose decreased, blood lactic acid decreased, blood pressure decreased, blood pressure diastolic increased, calcium ionised decreased, glucose tolerance impaired on Sep 07, 2009 from JAPAN Additional patient health information: Female patient , 83 years of age, was diagnosed with ectopic acth syndrome, hypertension, gastric ulcer, hypokalaemia, infection (What is infection?) and. Metopirone dosage: 500 Mg, Tid. During the same period patient was treated with MITOTANE (View Mitotane Review and Mitotane Label ), DIOVAN (160 Mg) (View Diovan Review and Diovan Label ), CONIEL (8 Mg) (View Coniel Review and Coniel Label ), OMEPRAL (20 Mg) (View Omepral Review and Omepral Label ), SLOW K (2400 Mg) (View Slow-k Review and Slow-k Label ), BAKTAR (Unk) (View Baktar Review and Baktar Label ), DIFLUCAN (100 Mg) (View Diflucan Review and Diflucan Label ). Patient was hospitalized.

6317730-7 | Adrenocortical Insufficiency Acute, Blood Calcium Decreased, Blood Glucose Decreased, Blood Lactic Acid Decreased, Blood Pressure Decreased, Haematocrit Decreased, Haemoglobin Decreased, Heart Rate Increased, Pco2 Decreased
Adverse event was reported on Aug 10, 2009 by a Female patient taking Metopirone (View Usage) (Dosage: 500 Mg, Tid) was diagnosed with ectopic acth syndrome, hypertension, gastric ulcer, hypokalaemia, infection (What is infection?), diabetes mellitus and. Location: JAPAN , 83 years of age, Patient had the following side effects: adrenocortical insufficiency acute, blood calcium decreased, blood glucose decreased, blood lactic acid decreased, blood pressure decreased, haematocrit decreased, haemoglobin decreased, heart rate increased, pco2 decreased. During the same period patient was treated with MITOTANE (View Mitotane Review and Mitotane Label ), DIOVAN (160 Mg) (View Diovan Review and Diovan Label ), CONIEL (8 Mg) (View Coniel Review and Coniel Label ), OMEPRAL (20 Mg) (View Omepral Review and Omepral Label ), SLOW K (2400 Mg) (View Slow-k Review and Slow-k Label ), BAKTAR (Unk) (View Baktar Review and Baktar Label ), DIFLUCAN (100 Mg) (View Diflucan Review and Diflucan Label ), HUMULIN R (14 Df) (View Humulin R Review and Humulin R Label ). Patient was hospitalized.

6293346-6 | Acute Respiratory Distress Syndrome, Multi-organ Failure, Pneumocystis Jiroveci Pneumonia, Respiratory Failure
on Mar 17, 2009 Male patient from GERMANY , 36 years of age, was diagnosed with hypercorticoidism, glucocorticoids abnormal and was treated with Metopirone (View Usage). After Metopirone was administered, patient had the following side effects: acute respiratory distress syndrome, multi-organ failure, pneumocystis jiroveci pneumonia, respiratory failure. Metopirone dosage: 500 Mg, Unk. During the same period patient was treated with HYDROCORTISONE (100 Mg /day) (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6219625-6 | Blood Corticotrophin Decreased, Blood Cortisol Decreased, Blood Cortisol Increased, Headache, Hyponatraemia, Hypophysectomy, Malaise, Nausea, Pituitary Haemorrhage
on May 26, 2009 Female patient from JAPAN , weighting 107.6 lb, was diagnosed with pituitary-dependent cushing's syndrome, hypokalaemia, gastritis, hypothyroidism, prophylaxis, pneumonia (What is pneumonia?) and was treated with Metopirone (View Usage). Patient experienced the following unwanted or unexpected effects: blood corticotrophin decreased, blood cortisol decreased, blood cortisol increased, headache (What is headache?), hyponatraemia, hypophysectomy, malaise, nausea (What is nausea?), pituitary haemorrhage. Metopirone dosage: 250 Mg, Qid. During the same period patient was treated with DEXAMETHASONE (0.5 Mg) (View Dexamethasone Review and Dexamethasone Label ), SLOW K (2.4 G, Unk) (View Slow-k Review and Slow-k Label ), TAKEPRON (15 Mg, Unk) (View Takepron Review and Takepron Label ), THYRADIN S (25 Ug, Unk) (View Thyradin S Review and Thyradin S Label ), EPLERENONE (50 Mg, Unk) (View Eplerenone Review and Eplerenone Label ), SELBEX (200 Mg, Unk) (View Selbex Review and Selbex Label ), CRAVIT (300 Mg, Unk) (View Cravit Review and Cravit Label ).

6193312-5 | Headache, Hypophysectomy, Nausea, Pituitary Haemorrhage, Pituitary Tumour
Patient was taking Metopirone (View Usage). Patient had the following side effects: headache (What is headache?), hypophysectomy, nausea (What is nausea?), pituitary haemorrhage, pituitary tumour on May 07, 2009 from JAPAN Additional patient health information: Female patient , 32 years of age, weighting 107.6 lb, was diagnosed with pituitary-dependent cushing's syndrome and. Metopirone dosage: .

6127458-4 | Headache, Hypophysectomy, Nausea, Pituitary Haemorrhage, Pituitary Tumour
Adverse event was reported on Mar 12, 2009 by a Female patient taking Metopirone (View Usage) (Dosage: ) was diagnosed with pituitary-dependent cushing's syndrome and. Location: JAPAN , 32 years of age, weighting 107.6 lb, After Metopirone was administered, patient had the following side effects: headache (What is headache?), hypophysectomy, nausea (What is nausea?), pituitary haemorrhage, pituitary tumour.

6119375-0 | Pituitary Haemorrhage
on Mar 04, 2009 Female patient from JAPAN , 32 years of age, was diagnosed with pituitary-dependent cushing's syndrome and was treated with Metopirone (View Usage). Patient experienced the following unwanted or unexpected effects: pituitary haemorrhage. Metopirone dosage: .

6112505-6 | Blood Pressure Decreased, Bronchoalveolar Lavage, Malaise, Oral Candidiasis, Oxygen Saturation Decreased, Platelet Count Decreased, Pneumocystis Jiroveci Pneumonia, Pyrexia, Respiratory Failure
on Mar 06, 2009 Male patient from JAPAN , 57 years of age, was diagnosed with cushing's syndrome and was treated with Metopirone (View Usage). Patient had the following side effects: blood pressure decreased, bronchoalveolar lavage, malaise, oral candidiasis, oxygen saturation decreased, platelet count decreased, pneumocystis jiroveci pneumonia, pyrexia, respiratory failure. Metopirone dosage: . Patient was hospitalized.

6099847-8 | Blood Pressure Decreased, Bronchoalveolar Lavage, Malaise, Oxygen Saturation Decreased, Pneumocystis Jiroveci Pneumonia, Pyrexia
Patient was taking Metopirone (View Usage). After Metopirone was administered, patient had the following side effects: blood pressure decreased, bronchoalveolar lavage, malaise, oxygen saturation decreased, pneumocystis jiroveci pneumonia, pyrexia on Feb 25, 2009 from JAPAN Additional patient health information: Male patient , 57 years of age, was diagnosed with cushing's syndrome and. Metopirone dosage: . Patient was hospitalized.

6034671-3 | Blood Pressure Decreased, Bronchoalveolar Lavage, Malaise, Oxygen Saturation Decreased, Pneumocystis Jiroveci Pneumonia, Pyrexia
Adverse event was reported on Dec 22, 2008 by a Male patient taking Metopirone (View Usage) (Dosage: ) was diagnosed with cushing's syndrome and. Location: JAPAN , 57 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, bronchoalveolar lavage, malaise, oxygen saturation decreased, pneumocystis jiroveci pneumonia, pyrexia. Patient was hospitalized.

6022536-2 | Adrenalectomy, Blood Pressure Decreased, Bronchoalveolar Lavage, Malaise, Oxygen Saturation Decreased, Pneumocystis Jiroveci Pneumonia, Pyrexia
on Dec 22, 2008 Male patient from JAPAN , 57 years of age, was diagnosed with cushing's syndrome and was treated with Metopirone (View Usage). Patient had the following side effects: adrenalectomy, blood pressure decreased, bronchoalveolar lavage, malaise, oxygen saturation decreased, pneumocystis jiroveci pneumonia, pyrexia. Metopirone dosage: . Patient was hospitalized.

6020272-X | Bronchoalveolar Lavage, Pneumocystis Jiroveci Pneumonia
on Dec 19, 2008 Male patient from JAPAN , 57 years of age, was diagnosed with cushing's syndrome and was treated with Metopirone (View Usage). After Metopirone was administered, patient had the following side effects: bronchoalveolar lavage, pneumocystis jiroveci pneumonia. Metopirone dosage: . Patient was hospitalized.

6020263-9 | Adrenal Insufficiency, Blood Pressure Systolic Decreased, Psychiatric Symptom, Psychotic Disorder, Pyrexia, Stupor
Patient was taking Metopirone (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal insufficiency, blood pressure systolic decreased, psychiatric symptom, psychotic disorder (What is psychotic disorder?), pyrexia, stupor on Dec 18, 2008 from JAPAN Additional patient health information: Female patient , weighting 103.6 lb, was diagnosed with acth stimulation test, acth-producing pituitary tumour and. Metopirone dosage: 250 Mg 6 Capsules A Day. During the same period patient was treated with LAXOBERON (View Laxoberon Review and Laxoberon Label ). Patient was hospitalized.

6005960-3 | Pneumocystis Jiroveci Pneumonia
Adverse event was reported on Dec 10, 2008 by a Male patient taking Metopirone (View Usage) (Dosage: ) was diagnosed with cushing's syndrome and. Location: JAPAN , 57 years of age, Patient had the following side effects: pneumocystis jiroveci pneumonia. Patient was hospitalized.

5999925-5 | Adrenal Insufficiency, Altered State Of Consciousness, Blood Pressure Systolic Decreased, Pyrexia, Stupor
on Dec 05, 2008 Female patient from JAPAN , weighting 103.6 lb, was diagnosed with acth stimulation test and was treated with Metopirone (View Usage). After Metopirone was administered, patient had the following side effects: adrenal insufficiency, altered state of consciousness, blood pressure systolic decreased, pyrexia, stupor. Metopirone dosage: 250 Mg 6 Capsules A Day. During the same period patient was treated with LAXOBERON (View Laxoberon Review and Laxoberon Label ). Patient was hospitalized.

5631792-1 | Adrenal Insufficiency, Blood Corticotrophin Decreased, Blood Cortisol Decreased
on Feb 07, 2008 Female patient from JAPAN , 64 years of age, weighting 105.8 lb, was diagnosed with pituitary-dependent cushing's syndrome, mental disorder, nephrogenic diabetes insipidus, gastritis and was treated with Metopirone (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal insufficiency, blood corticotrophin decreased, blood cortisol decreased. Metopirone dosage: 750mg/d. During the same period patient was treated with DEPAKENE (600mg/d) (View Depakene Review and Depakene Label ), SERENACE (6mg/d) (View Serenace Review and Serenace Label ), AKINETON (3mg/d) (View Akineton Review and Akineton Label ), TRICHLORMETHIAZIDE (1.5 Mg/d) (View Trichlormethiazide Review and Trichlormethiazide Label ), GASTER D (20 Mg) (View Gaster D Review and Gaster D Label ).

5592837-0 | Adrenal Insufficiency, Blood Corticotrophin Decreased, Blood Cortisol Decreased
Patient was taking Metopirone (View Usage). Patient had the following side effects: adrenal insufficiency, blood corticotrophin decreased, blood cortisol decreased on Jan 09, 2008 from JAPAN Additional patient health information: Female patient , 64 years of age, weighting 105.8 lb, was diagnosed with pituitary-dependent cushing's syndrome, mental disorder, nephrogenic diabetes insipidus and. Metopirone dosage: 750mg/d. During the same period patient was treated with DEPAKENE (600mg/d) (View Depakene Review and Depakene Label ), SERENACE (6mg/d) (View Serenace Review and Serenace Label ), AKINETON (3mg/d) (View Akineton Review and Akineton Label ), TRICHLORMETHIAZIDE (1.5 Mg/d) (View Trichlormethiazide Review and Trichlormethiazide Label ), GASTER D (20 Mg) (View Gaster D Review and Gaster D Label ).

5571587-0 | Blood Corticotrophin Decreased, Blood Cortisol Decreased
Adverse event was reported on Dec 12, 2007 by a Female patient taking Metopirone (View Usage) (Dosage: 750mg/d) was diagnosed with pituitary-dependent cushing's syndrome, nephrogenic diabetes insipidus and. Location: JAPAN , 64 years of age, After Metopirone was administered, patient had the following side effects: blood corticotrophin decreased, blood cortisol decreased. During the same period patient was treated with DEPAKENE (600mg/d) (View Depakene Review and Depakene Label ), SERENACE (6mg/d) (View Serenace Review and Serenace Label ), AKINETON (3mg/d) (View Akineton Review and Akineton Label ), TRICHLORMETHIAZIDE (2mg/d) (View Trichlormethiazide Review and Trichlormethiazide Label ).

5570418-2 | Blood Corticotrophin Decreased, Blood Cortisol Decreased
on Dec 12, 2007 Female patient from JAPAN , 64 years of age, was diagnosed with pituitary-dependent cushing's syndrome, nephrogenic diabetes insipidus and was treated with Metopirone (View Usage). Patient experienced the following unwanted or unexpected effects: blood corticotrophin decreased, blood cortisol decreased. Metopirone dosage: 750mg/d. During the same period patient was treated with DEPAKENE (600mg/d) (View Depakene Review and Depakene Label ), SERENACE (6mg/d) (View Serenace Review and Serenace Label ), AKINETON (3mg/d) (View Akineton Review and Akineton Label ), TRICHLORMETHIAZIDE (2mg/d) (View Trichlormethiazide Review and Trichlormethiazide Label ).

5545263-4 | Blood Corticotrophin Decreased, Blood Cortisol Decreased
on Nov 29, 2007 Female patient from JAPAN , 64 years of age, was diagnosed with pituitary-dependent cushing's syndrome, nephrogenic diabetes insipidus and was treated with Metopirone (View Usage). Patient had the following side effects: blood corticotrophin decreased, blood cortisol decreased. Metopirone dosage: 750mg/d. During the same period patient was treated with DEPAKENE (600mg/d) (View Depakene Review and Depakene Label ), SERENACE (6mg/d) (View Serenace Review and Serenace Label ), AKINETON (3mg/d) (View Akineton Review and Akineton Label ), TRICHLORMETHIAZIDE (2mg/d) (View Trichlormethiazide Review and Trichlormethiazide Label ).

5406760-5 | Hepatitis Toxic
Patient was taking Metopirone (View Usage). After Metopirone was administered, patient had the following side effects: hepatitis toxic on Jul 30, 2007 from BELGIUM Additional patient health information: Male patient , 59 years of age, was diagnosed with carcinoid syndrome and. Metopirone dosage: 3 X 2 250 Mg Tablets/day. During the same period patient was treated with NIZORAL (Unk, Unk) (View Nizoral Review and Nizoral Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), HALDOL (View Haldol Review and Haldol Label ), COMBURIC (View Comburic Review and Comburic Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), INSULIN RETARD LEO (View Insulin Retard Leo Review and Insulin Retard Leo Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

5270669-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, C-reactive Protein Increased, Carcinoid Tumour Pulmonary, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Pneumonia, Pyrexia
Adverse event was reported on Mar 08, 2007 by a Female patient taking Metopirone (View Usage) (Dosage: 750 Mg/d) was diagnosed with cushing's syndrome and. Location: JAPAN , 58 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, c-reactive protein increased, carcinoid tumour pulmonary, gamma-glutamyltransferase increased, hepatic function abnormal, pneumonia (What is pneumonia?), pyrexia. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), SIGMART (View Sigmart Review and Sigmart Label ), DEPAKENE (View Depakene Review and Depakene Label ), ALOSENN (View Alosenn Review and Alosenn Label ), MICARDIS (View Micardis Review and Micardis Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SLOW K (View Slow-k Review and Slow-k Label ). Patient was hospitalized.

5234312-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, C-reactive Protein Increased, Carcinoid Tumour Pulmonary, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Pneumonia, Pyrexia
on Jan 29, 2007 Female patient from JAPAN , 58 years of age, weighting 132.3 lb, was diagnosed with cushing's syndrome and was treated with Metopirone (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, c-reactive protein increased, carcinoid tumour pulmonary, gamma-glutamyltransferase increased, hepatic function abnormal, pneumonia (What is pneumonia?), pyrexia. Metopirone dosage: 750 Mg/d. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), SIGMART (View Sigmart Review and Sigmart Label ), DEPAKENE (View Depakene Review and Depakene Label ), ALOSENN (View Alosenn Review and Alosenn Label ), MICARDIS (View Micardis Review and Micardis Label ), NORVASC (View Norvasc Review and Norvasc Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), SLOW K (View Slow-k Review and Slow-k Label ). Patient was hospitalized.

5166648-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, C-reactive Protein Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Pneumonia, Pyrexia, White Blood Cell Count Increased
on Oct 30, 2006 Female patient from JAPAN , 58 years of age, weighting 132.3 lb, was diagnosed with cushing's syndrome and was treated with Metopirone (View Usage). After Metopirone was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, c-reactive protein increased, gamma-glutamyltransferase increased, hepatic function abnormal, pneumonia (What is pneumonia?), pyrexia, white blood cell count increased. Metopirone dosage: 750 Mg/d. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), SIGMART (View Sigmart Review and Sigmart Label ), DEPAKENE (View Depakene Review and Depakene Label ), ALOSENN (View Alosenn Review and Alosenn Label ), MICARDIS (View Micardis Review and Micardis Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SLOW K (View Slow-k Review and Slow-k Label ).

5166611-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, C-reactive Protein Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Pneumonia, Pyrexia, White Blood Cell Count Increased
Patient was taking Metopirone (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, c-reactive protein increased, gamma-glutamyltransferase increased, hepatic function abnormal, pneumonia (What is pneumonia?), pyrexia, white blood cell count increased on Oct 30, 2006 from JAPAN Additional patient health information: Female patient , 58 years of age, weighting 132.3 lb, was diagnosed with cushing's syndrome and. Metopirone dosage: 750 Mg/d. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), SIGMART (View Sigmart Review and Sigmart Label ), DEPAKENE (View Depakene Review and Depakene Label ), ALOSENN (View Alosenn Review and Alosenn Label ), MICARDIS (View Micardis Review and Micardis Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SLOW K (View Slow-k Review and Slow-k Label ).

5155217-8 | Hypoxia, Oxygen Saturation Decreased
Adverse event was reported on Nov 08, 2006 by a Female patient taking Metopirone (View Usage) (Dosage: 750 Mg/day) was diagnosed with cushing's syndrome and. Location: JAPAN , 76 years of age, Patient had the following side effects: hypoxia, oxygen saturation decreased. During the same period patient was treated with DIOVAN (80 Mg/day) (View Diovan Review and Diovan Label ), LOCHOL (20 Mg/day) (View Lochol Review and Lochol Label ), CONIEL (4 Mg/day) (View Coniel Review and Coniel Label ). Patient was hospitalized.

5031371-3 | Adrenal Cortical Insufficiency, Pneumocystis Jiroveci Pneumonia, Pyrexia, Respiratory Distress, Respiratory Failure
on Mar 15, 2006 Female patient from JAPAN , 62 years of age, was diagnosed with hypercorticoidism and was treated with Metopirone (View Usage). After Metopirone was administered, patient had the following side effects: adrenal cortical insufficiency, pneumocystis jiroveci pneumonia, pyrexia, respiratory distress, respiratory failure. Metopirone dosage: 1.5-0.5 G/d. During the same period patient was treated with DEXAMETHASONE TAB (1 Mg/d) (View Dexamethasone Tab Review and Dexamethasone Tab Label ). Patient was hospitalized.

5028409-6 | Carcinoid Tumour Pulmonary, Pneumocystis Jiroveci Pneumonia
on May 31, 2006 Female patient from JAPAN , 75 years of age, was diagnosed with ectopic acth syndrome and was treated with Metopirone (View Usage). Patient experienced the following unwanted or unexpected effects: carcinoid tumour pulmonary, pneumocystis jiroveci pneumonia. Metopirone dosage: 750 Mg/day.

5022034-9 | Carcinoid Tumour Pulmonary, Pneumocystis Jiroveci Pneumonia
Patient was taking Metopirone (View Usage). Patient had the following side effects: carcinoid tumour pulmonary, pneumocystis jiroveci pneumonia on May 31, 2006 from JAPAN Additional patient health information: Female patient , 75 years of age, was diagnosed with ectopic acth syndrome and. Metopirone dosage: 750 Mg/day.